Alzheimer’s disease research: A game of connect the dots

Gerontology

Volumn 43, Issue 1-2, 1997, Pages 8-19

  Adams, Charley ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Alzheimer s; Amyloid; ApoE; APP; Endosomal lysosomal; Glia; Tau

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PROTEIN; APOLIPOPROTEIN E; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; AUTOPSY; ENDOSOME; HUMAN; HYPOTHESIS; LYSOSOME; MICROGLIA; MICROTUBULE; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SENILE PLAQUE;

ALZHEIMER DISEASE; HUMANS;

EID: 0031021063     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213832     Document Type: Article

References (56)

1. Busfield F, Goate AM: The genetics of Alzheimer's disease and mutations in the amyloid G-protein precursor gene: in Goate AM, Ashall F (eds): Pathobiology of Alzheimer’s Disease. London, Academic Press. 1995. pp 59-78.
2. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi FI, Lin C, Li G, Holman K, Tsu-da T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainera I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanscau P, Polinsky RJ, Wasco W, Da Silva HA, Haines JL, Pericak-Vance MA, Tarzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 1995:375: 754-760.
3. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu C, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu YH, Guenette SY, Galas D, Nemcns E, Wijsman EM, Bird TD, Schellen-bcrg GD, Tanzi RE: Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 1995:269:973-977.
4. Sheu KF, Cooper AJ, Koike K, Koike M, Lindsay G, Blass JP: Abnormality of the a-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease. Ann Neurol 1994;35:312-318.
5. Ali G, Wasco W, Cai X, Szabo P, Sheu KF, Cooper AJ, Gaston SM, Gusella JF, Tanzi RE, Blass JP: Isolation, characterization, and mapping of gene encoding dihydrolipoyl succinyltransferase (E2k) of human a-ketoglutarate dehydrogenase complex. Somatic Cell Mol Genet 1994; 20:99-105.
6. Glcnncr GG, Wong CW: Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Com-mun 1984:120:885-890.
7. Kang J, Lemaire HG, Unterbeck A, Salbaunt JM, Masters CL, Grze-schik KH, Multhaup G, Beyreuther K, Muller-Hill B: The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell surface receptor. Nature 1987;325:733-736.
8. Wagner SL: Biological Functions of the antyloid-p protein precursor: in Goate AM, Ashall F (eds): Pathobio-logy of Alzheimer’s Disease. London, Academic Press. 1995. pp 167-173.
9. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H: Novel precursor of Alzheimer’s disease shows protease inhibitory activity. Nature 1988:331:530-532.
10. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD: Molecular Biology of the Cell, ed 2. New York. Garland Publishing, 1989, pp 458-467.
11. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ: Targeting of cell-surface p-amvloid precursor protein to lysosomes: Alternative processing into amyloid-bearing fragments. Nature 1992;357:500-503.
12. Buxbaum JD, Gandy SE, Cicchctti P, Ehrlich ME, Czernik AJ, Fracasso RP, Rantabhadran TV, Unterbeck AJ, Greengard P: Processing of Alzheimer p/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci USA 1990;87:6003-6006.
13. Querfurth HW, Selkoe DJ: Calcium ionophore increases amyloid P peptide production by cultured cells. Biochemistry 1994;33:4550-4561.
14. Hardy JA, Higgins GA: Alzheimer's disease: The amyloid cascade hypothesis. Science 1992:256:184-185.
15. Arrigada PV, Growdon JH, Hedley-Whyte ET, Hyman BT: Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992; 42:631-639.
16. Braak H, Braak E: Ncuropathologi-cal stageing of Alzheimer-related changes. Acta Neuropathol 1991:82: 239-259.
17. Wischik CM, Lai R, Harrington CR, Mukaetova-Ladinska EB, Xuereb JH, Mena R, Edwards PC, Roth M: Structure, biochemistry and molecular pathogenesis of paired helical filaments in Alzheimer’s disease; in Goate AM, Ashall F (eds): Pathobio-logy of Alzheimer’s Disease. Academic Press. 1995, pp 12-18.
18. Wischik CM, Novak M, Thogcrsen HC, Edwards PC, Runswick MJ, Jakes R, Walker JE, Milstein C, Roth M, Klug A: Isolation of a fragment of tau from the core of the paired helical filament of Alzheimer’s disease. Proc Nall Acad Sci USA 1988;85:4506-4510.
19. Cleveland DW, Hwo SY, Kirschner MW: Purification of tau. a microtu-bule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 1977:116: 207-225.
20. Lee VM, Balin, BJ, Otvos L, Troja-nowski JQ: A68: A major subunit of paired helical filaments and deriva-tized forms of normal tau. Science 1991;251:675-678.
21. Gustke N, Steiner B, Mandclkow EM, Bicrnat J, Meyer HE, Goedert M, Mandetkow E: The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBSLett 1992;307:199-205.
22. Trojanowski JQ, Lee VM: Paired helical filament tau in Alzheimer’s disease: The kinase connection. Am J Pathol 1994;144:449-453.
23. Matsuo ES, Shin RW, Billingsley ML, deVoorde AV, O’Connor M, Trojanowski JQ, Lee VM: Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer’s disease paired helical filament tau. Neuron 1994: 13:989-1002.
24. Wischik CM, Edwards PC, Lai RY, Gertz HN, Xuereb NH, Paykcl ES, Brayne C, Huppert FA, Mukaetova-Ladinska EB, Mena R, Roth M, Harrington CR: Quantitative analysis of tau protein in paired helical filament preparations: Implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer’s disease. Neurobiol Aging 1995;16:409-431.
25. Papasozomenos SC, Binder LI: Phosphorylation determines two distinct species of tau in the central nervous system. Cell Motil Cyto-skeleton 1987;8:210-226.
26. Mahley RW: Apolipoprotcin E: Cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-629.
27. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM: Apolipo-protein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 1985;76:1501-1513.
28. Ignatius MJ, Gebickc-Hartcr PJ, Skene JH, Schilling JW, Wcisgraber KH, Mahley RW, Shooter EM: Expression of apolipoprotcin E during nerve degeneration and regeneration. Proc Natl Acad Sci USA 1986; 83:1125-1129.
29. Boyles JK, Zocllner CD, Anderson LJ, Kosik LM, Pitas RE, Weisgraber KH, Hui DY, Mahley RW, Ge-bicke-Harter PJ, Ignatius MJ, Shooter EM: A role for apolipopro-tein E, apolipoprotcin A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyclination of the rat sciatic nerve. J Clin Invest 1989:83: 1015-1031.
30. Rebeck GW, Reiter JS, Strickland DK, Hvmand BT: Apolipoprotcin E in sporadic Alzheimer’s disease: Allelic variation and receptor interactions. Neuron 1993:11:575-580.
31. Corder EH, Saunders AM, Strittmatter WJ, Schmcchel DE, Gaskcll PC, Small CJW, Roses AD, Haines JL, Pericak-Vancc MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 1993: 261:921-923.
32. Amouycl PA, Vidale O, Launay JM, Laplanche JL: The apolipoprotein E alleles as major susceptibility factors for Crcutzfeld-Jakob disease. Lancet 1994;344:1315-1318.
33. Weisgraber KH: Apolipoprotein E: Structurc-function relationships. AdvProtChem 1994;45:249-302.
34. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE: Differential effects of apolipo-proteins E3 and E4 on neuronal growth in vitro. Science 1994:264: 850-852.
35. Ma J, Yec A, Brewer HB, Das S, Potter H: Amyloid-associated proteins al-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer's p-protcin into filaments. Nature 1994;372:92-94.
36. Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA: Properties of the cndosomal-lysosomal sytcm in the human central nervous system: Disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Ncurosci 1996:16:186-199.
37. Okamoto K, Hirai S, lisuka T, Ya-nagisawa T, Watanabe M: Reexamination of granulovacuolar degeration. Acta Ncuropathol 1991:82: 340-345.
38. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SH: Alzheimer's disease: A double-labeling immunohistochemical study of senile plaques. Am J Pathol 1988; 132: 86-101.
39. Schechter R, Yen SH, Terry RD: Fibrous astrocytes in senile dementia of the Alzheimer’s type. J Ncuropathol Exp Neurol 1981:40:95-101.
40. Smith GM, Miller RH, Silver J: Changing role of forebrain astrocytes during development, regenerative failure, and induced regeneration upon transplantation. J Comp Neurol 1986;251:23-43.
41. McGeer PL, Akiyama H, Itagaki S, McGeer EG: Immune system response in Alzheimer's disease. Can J Neurol Sci 1989;16:516-527.
42. Jiang H, Burdick D, Glabe CG, Cot-man CW, Tenner AJ: P-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C Iq A chain. J Immunol 1994:152:5050-5059.
43. Griffin ST, Stanley LC, Ling C: Brain interleukin-1 and S-100 im-munoreactivity are elevated in Down’s syndrome and Alzheimer's disease. Proc Natl Acad Sci USA 1989;86:7611-7615.
44. Mrak RE, Sheng JG, Griffin WS: Glial cytokines in Alzheimer's disease: Review and pathogenic implications. Human Pathol 1995:26: 816-823.
45. Haga S, Ikcda K, Sato M, Ishii T: Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res 1993:601:88-94.
46. Goldgaber D, Harris HW, Hla T: Interleukin-1 regulates synthesis of amyloid p-protcin precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 1989:86:7606-7610.
47. Frcdcrickson RCA, Brundcn KR: New opportunities in AD research: Roles of immunoinflammatory responses and glia. Alzheimer’s Dis Assoc Disord 1994:8:159-165.
48. Crapper Mclachlan DR: Aluminum and Alzheimer's disease. Neurobiol Aging 1986;7:525-532.
49. Rasmusson DX, Brandt J, Martin DB, Folstein MF: Head injury as a risk factor in Alzheimer’s disease. Brain Injury 1995:9:213-219.
50. Henderson AS, Jorm AF, Korten AE, Creasey H, McCusker E, Broe GA, Longlev W, Anthony JC: Environmental risk factors for Alzheimer's disease: Their relationship to the age of onset and to familial or sporadic types. Psychol Med 1992: 22:429-436.
51. Breitner JC, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, Pericak-Vance MA, Saunders AM: Delayed onset of Alzheimer’s disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging I995;26: 523-530.
52. Edland SD, Silverman J, Peskind ER, Tsuang D, Wijsman E, Morris JC: increased risk of dementia in mothers of Alzheimer’s disease cases: Evidence for maternal inheritance. Soc Neurosci 1995;poster 581.1. abstr.
53. Baker AC, Ko LW, Blass JP: Systemic manifestations of Alzheimer’s disease. Age 1988; 11:60-65.
54. Greenberg SM, Kosik KS: Secreted p-APP stimulates MAP kinase and phosphorylation of tau in neurons. Neurobiol Aging 1995;16:403-407.
55. Troncoso JC, Sternberger NH, Stemberger LA, Hoffman PN, Price DL: lmmunocytochemical studies of ncurofilament antigens in the neurofibrillary pathology induced by aluminum. Brain Res 1986,364: 295-300.
56. Games D, Adams D, Alessandrini P, Barbour P, Bcrthelette P, Black-well C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hago-plan S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Maslia E, McConlogue L, Montoya-Zavala M, Muckc L, Paganini L, Penniman E, Pow'er M, Schenk D, Scubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J: Alzheimer’s-type neuropathology in transgenic mice overexpressing V717F/p-amy-loid precursor protein. Nature 1995: 373:523-527.